default author photo

Svenja Hardtke

University of Hamburg - University Medical Center Hamburg-Eppendorf

Martinistrasse 52

Hamburg, D - 20246

Germany

SCHOLARLY PAPERS

1

DOWNLOADS

133

TOTAL CITATIONS

2

Scholarly Papers (1)

1.

The Safety, Immunogenicity, and Optimal Dosing of an MVA-Based Vaccine Against MERS Coronavirus in Healthy Adults: A Phase 1b, Randomised, Placebo-Controlled, Double-Blind Clinical Trial

Number of pages: 31 Posted: 24 Apr 2024
Erasmus University Rotterdam (EUR) - Department of Viroscience, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Marburg, Philipps University Marburg - Institute of Virology, University of Marburg, University of Hamburg - University Medical Center Hamburg-Eppendorf, Erasmus Medical Center - Viroscience Department, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, Erasmus University Rotterdam (EUR) - Department of Viroscience, Ludwig Maximilian University of Munich (LMU), University of Marburg, Erasmus Medical Center - Viroscience Department, University Medical Center Hamburg-Eppendorf - First Department of Medicine and Independent
Downloads 133 (547,695)
Citation 2

Abstract:

Loading...

Middle East respiratory syndrome coronavirus, MERS-CoV, MERS, modified vaccinia virus Ankara, modified vaccinia Ankara, MVA, MVA-MERS-S